Johnson & Johnson Q3 Earnings Preview: Dividend Dependability And Steady Growth

Johnson & Johnson (NYSE: JNJ ) , a global healthcare giant with roots going back to 1886, is set to drop its earnings report for the fiscal quarter ending September 2024. The company, known for its wide range of medical devices, pharmaceuticals, and consumerThe mission of Grassroots Trading rests on the following principles: providing objective, unbiased, and balanced research, backed by solid data and completely void of emotional influences or preference for companies; focusing on small- to mid-cap compani ...